Navigation Links
TPI Business and Development Profile Updated on OneMedDatabase
Date:4/4/2011

CHENGDU, China, April 4, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals has updated its corporate business & development information on OneMedDatabase, a division of OneMedPlace, a New York-based healthcare research and business & development firm.

The profile is to serve as a portal for TPI in the development of partnership with U.S. as well as international pharmaceutical companies for the further growth expansion via TPI's in-depth coverage of pharmaceutical sales network in China and TPI's upcoming macrolide antibiotic API business.

The updated profile of TPI along with an interview with the management can be found via the following link: http://www.onemedplace.com/database/list/cid/14315

About OneMedPlace

OneMedPlace (OMP), based in New York, is a healthcare research company that manages a business development platform to help emerging healthcare and life sciences companies maximize their potentials. OMP provides companies and investors with efficient access to information about potential opportunities around the world through an integrated set of tools including:

OneMedDatabase: Over 8,000 companies and resources.

OneMedForum: a biannual business development and investment conferences in San Francisco (January) and New York City (June).

OneMedTV: Documentaries on promising companies and technologies and important healthcare events.

Sentinel: weekly e-newsletter tracking the major healthcare industrial trends.

For more information regarding OneMedPlace, please visit: www.OneMedPlace.com

About TPI

Headquartered at Chengdu, China, TPI is a pharmaceutical company that specializes in the development, manufacturing, marketing and sales of patented biopharmaceutical, modernized traditional Chinese medicines, branded generics and other pharmaceuticals. TPI currently manufactures a comprehensive portfolio of 56 products, 23 of which are listed in the highly selective national medicine reimbursement list, 7 are included in the essential drug list of China. TPI currently has a pipeline of 10 late stage products pending the SFDA approval that target various high incidence healthcare indications. TPI has an extensive nationwide distribution network with a sales force of 730 sales representatives out of totaled 1,365 employees.

For more information about TPI, please visit:  http://www.tianyinpharma.com.

Safe Harbor Statement

The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.

For more information, please contact:

James Jiayuan Tong M.D. Ph.D.
Chief Financial Officer, Chief Business & Development Officer
Director
Tianyin Pharmaceutical Co., Inc.
Web:     http://www.tianyinpharma.com
Email:   Dr.Tong@tianyinpharma.com

Tel:  +86-28-8551-6696 (Chengdu, China)
       +86-134-3655-0011 (China)
       +1-949-350-6999 (U.S.)

Address:

23rd Floor, Unionsun Yangkuo Plaza
No. 2, Block 3, South Renmin Road
Chengdu, 610041
China


'/>"/>
SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kronos Announces First Quarter Business Update and Financial Results
2. Growth Achieved in Spherixs Health Sciences Consulting Business
3. ImaRx Therapeutics Transitions Business Strategy
4. Argonauta Communications Certified as Women-Owned Business by the Womens Business Enterprise National Council (WBENC)
5. New Pharma Business Model Increases Pressure on Staff Communicating Trial Data
6. Small Business Innovation Research Program Awards Grant to Biomoda
7. American Dairy Provides Business Update
8. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
9. Pharmos Issues Business Update on Dextofisopam Trial and Financing
10. One Call Now Offers Notification Service at NO CHARGE for Governments, Schools, Businesses, Religious Organizations and Others in Response to Swine Flu Outbreak
11. Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... February 11, 2016 ,   ... EUR 1,377.2m  Adjusted EBITDA climbs to EUR 277.9m   ... 3.41  Proposed dividend of EUR 0.85 per share (2014: ... tubing business and refinancing successfully completed  Approximately 9% ... organic basis  Adjusted EBITDA expected for 2016 at ...
(Date:2/10/2016)... DALLAS , Feb. 10, 2016  Fotona, based in ... it will launch its new ST PRO Lightwalker dental laser ... Chicago Dental Society from 25-27 February, 2016 in booth #4815. ... tissue dental laser with many of the features of the ... $49,900, the ST PRO competitive price will be very attractive ...
(Date:2/10/2016)... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), today announced ... full year ended December 31, 2015. ... year for Vanda with the continued growth of HETLIOZ ... HETLIOZ for Non-24," said Mihael H. Polymeropoulos, M.D., Vanda,s ... U.S. product portfolio builds on this success and underscores ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... February 11, 2016 , ... Dickinson Insurance & Financial Services continues their commitment ... in support of a local boy named Barrett, who has been fighting ALL leukemia ... and rally support for, all local families dealing with childhood cancer. Information on how ...
(Date:2/11/2016)... , ... February 11, 2016 , ... Be Well ... office in the heart of Old Town at 108 South Columbus St, Suite 201, ... the highest level of medical care in the convenience of their homes, offices or ...
(Date:2/11/2016)... ... 11, 2016 , ... Husted Kicking has completed its Third Annual ... 6th & 7th, 2016 according to kicking coach Michael Husted. , “This event serves ... NFL’s combine in Indianapolis,” says Husted. “The NFL uses a third party organization to ...
(Date:2/11/2016)... ... February 11, 2016 , ... Research led ... rates of several common cancer screenings, especially among women. Cancer screenings are often ... rates. , The study,“What Does Medicaid Expansion Mean for Cancer Screening and ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... as the World Molecular Imaging Congress (WMIC), will be held in New York ... meeting is “Imaging Biology…Improving Therapy.” The congress will highlight and emphasize how imaging ...
Breaking Medicine News(10 mins):